U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Manganese Difluoride is a light pink crystalline solid composed of manganese and fluoride with the formula MnF2. Manganese Difluoride is made by treating manganese and diverse compounds of manganese(II) in hydrofluoric acid. Manganese Difluoride is used in the manufacture of special kinds of glass and lasers.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Manganese is used for prevention and treatment of manganese deficiency, a condition in which the body doesn’t have enough manganese.
Primary
Unknown

Approved Use

Manganese is used for weak bones (osteoporosis).
Palliative
Unknown

Approved Use

Early research suggests that taking manganese along with calcium helps improve symptoms of PMS, including pain, crying, loneliness, anxiety, restlessness, irritability, mood swings, depression, and tension.
Curative
MANGANESE SULFATE

Approved Use

Manganese Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Primary
MANGANESE SULFATE

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Cytochrome oxidase determination using a manganese citrate complex.
1970
Effect of quantity and route of administration of manganese monoxide on feed intake and serum manganese in ruminants.
1985 Feb
Dietary calcium and manganese effects on menstrual cycle symptoms.
1993 May
Differential ability of transition metals to induce pulmonary inflammation.
2001 Nov 15
Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity.
2007 Jun
Yolk-Shell MnO@ZnMn(2) O(4) /N-C Nanorods Derived from α-MnO(2) /ZIF-8 as Anode Materials for Lithium Ion Batteries.
2016 Oct
Intramolecular Aminoalkoxylation of Unfunctionalized Olefins via Intramolecular Iodoamination and Aziridinium Ion Ring-Opening Sequence.
2017 Apr 7
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment: In vitro cytotoxicity of manganese oxide (MnO) using live/dead cell assay, lactate dehydrogenase assay, and reactive oxygen species detection with variation of the concentration of nanoparticles (5-500 ug/ml), incubation time (18-96 h), and different human cell lines (lung adenocarcinoma, breast cancer cells, and glioblastoma cells) was studied. The cytotoxic effect was negligible for 18 h incubation even at highest concentration of 500 ug/ml MnO nanoparticle.
Unknown
Substance Class Mixture
Created
by admin
on Thu Jul 06 03:07:54 UTC 2023
Edited
by admin
on Thu Jul 06 03:07:54 UTC 2023
Record UNII
9YY2F980SV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MANGANESE GLUCONATE, UNSPECIFIED FORM
Common Name English
MANGANESE GLUCONATE
EP   INCI   MART.   USP   VANDF   WHO-DD  
INCI  
Preferred Name English
MANGANESE GLUCONATE [USP MONOGRAPH]
Common Name English
MANGANESE GLUCONATE [VANDF]
Common Name English
MANGANESE GLUCONATE [MART.]
Common Name English
MANGANESE GLUCONATE IS DRIED OR CONTAINS TWO MOLECULES OF WATER OF HYDRATION
Common Name English
MANGANESE GLUCONATE [EP MONOGRAPH]
Common Name English
MANGANUM GLUCONICUM
Common Name English
Manganese gluconate [WHO-DD]
Common Name English
MANGANESE GLUCONATE [INCI]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 184.1452
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
Code System Code Type Description
RXCUI
52403
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
PRIMARY RxNorm
DAILYMED
9YY2F980SV
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
PRIMARY
DRUG BANK
DB11141
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
PRIMARY
FDA UNII
9YY2F980SV
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
PRIMARY
EVMPD
SUB14471MIG
Created by admin on Thu Jul 06 03:07:54 UTC 2023 , Edited by admin on Thu Jul 06 03:07:54 UTC 2023
PRIMARY
Related Record Type Details
UNSPECIFIED INGREDIENT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY
Definition References